Ablefoni, M.; Surup, H.; Ehrengut, C.; Schindler, A.; Seehofer, D.; Denecke, T.; Meyer, H.-J.
Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis. J. Clin. Med. 2021, 10, 5289.
https://doi.org/10.3390/jcm10225289
AMA Style
Ablefoni M, Surup H, Ehrengut C, Schindler A, Seehofer D, Denecke T, Meyer H-J.
Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis. Journal of Clinical Medicine. 2021; 10(22):5289.
https://doi.org/10.3390/jcm10225289
Chicago/Turabian Style
Ablefoni, Maxime, Hans Surup, Constantin Ehrengut, Aaron Schindler, Daniel Seehofer, Timm Denecke, and Hans-Jonas Meyer.
2021. "Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis" Journal of Clinical Medicine 10, no. 22: 5289.
https://doi.org/10.3390/jcm10225289
APA Style
Ablefoni, M., Surup, H., Ehrengut, C., Schindler, A., Seehofer, D., Denecke, T., & Meyer, H.-J.
(2021). Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis. Journal of Clinical Medicine, 10(22), 5289.
https://doi.org/10.3390/jcm10225289